Baxter’s efforts this summer to correct high-risk issues with its infusion pumps has gotten more complicated. Last month, the company and the FDA alerted the public to a problem with the large-volume ...
Hosted on MSN
Baxter targets 5%-6% 2025 revenue growth amid Novum IQ pump success and operational recovery
Earnings Call Insights: Baxter International Inc. (NYSE:BAX) Q4 2024 Interim CEO Brent Shafer highlighted the completion of the Vantive sale as a significant milestone in Baxter's transformation ...
Baxter International Inc. (NYSE:BAX) is one of the top cheap stocks under $20 to buy now. On December 12, Wells Fargo analyst ...
Global Intelligent Intravenous Infusion Pumps Market Trends 2023: This research elaborates on the industrial trends for topmost industries for the insights on Intelligent Intravenous Infusion Pumps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback